778
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Preventing, producing, or reducing harm? Fitness doping risk and enabling environments

ORCID Icon & ORCID Icon
Pages 95-104 | Received 31 Aug 2020, Accepted 10 Dec 2020, Published online: 28 Dec 2020
 

Abstract

Policies and approaches addressing image and performance enhancing drug (IPED) use in the gym and fitness context, also known as fitness doping, vary widely by country. Fitness doping, and those who participate in it, maybe met with individual-level strategies ranging from criminal penalties to harm reduction efforts. This research compares two distinct approaches to fitness doping: Sweden’s prevention-based approach and Scotland’s harm reduction approach. Drawing on the risk environment framework, we show how national-level policies around possession, sale, and use that represent different approaches to IPEDs structure how to use is understood and experienced using two case studies: Sweden’s national PRODIS program and a steroid clinic in Glasgow, Scotland. The results highlight how individuals and communities respond to environmental constraints around IPEDs. Restrictive anti-doping environments produce a range of risks for people who use these substances and may prevent harm reduction. Less restrictive environments may allow for more harm reducing work, but the remaining prohibitions may still produce social, economic, and policy risks. We argue that formal harm reduction focused on the health and needs of those who use IPEDs offers an environment in which safer use is supported and promoted.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Notes

1 Formal ethical approval for this research was secured from the Regional Ethical Review Board of Linköping University (Ref. No. 46-09) and the General University Ethics Panel at the University of Stirling (No. 1006).

Additional information

Funding

This work was supported by the Swedish Research Council for Health, Working Life and Welfare (FORTE) (2017-01572).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.